1. Projecting the potential cost-effectiveness of dapagliflozin for chronic kidney disease in Kuwait. (31st December 2023) Authors: Swidan, Ahmed; Elsisi, Gihan Hamdy; Ibrahim, Mohamed M.; Aljazzar, Mohammad; Tawfik Sallam, Hossameldin Journal: Journal of medical economics Issue: Volume 26:Number 1(2023) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗